1071 related articles for article (PubMed ID: 26974331)
21. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
Sundaram C; Vydehi B; Meena K; Murthy J
Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
[TBL] [Abstract][Full Text] [Related]
22. The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies.
Helliwell TR; Man NT; Morris GE; Davies KE
Neuromuscul Disord; 1992; 2(3):177-84. PubMed ID: 1483043
[TBL] [Abstract][Full Text] [Related]
23. Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.
Li D; Bareja A; Judge L; Yue Y; Lai Y; Fairclough R; Davies KE; Chamberlain JS; Duan D
J Cell Sci; 2010 Jun; 123(Pt 12):2008-13. PubMed ID: 20483958
[TBL] [Abstract][Full Text] [Related]
24. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
25. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
[TBL] [Abstract][Full Text] [Related]
27. Unusually severe muscular dystrophy upon in-frame deletion of the dystrophin rod domain and lack of compensation by membrane-localized utrophin.
Gorokhova S; Schessl J; Zou Y; Yang ML; Heydemann PT; Sufit RL; Meilleur K; Donkervoort S; Medne L; Finkel RS; Bönnemann CG
Med; 2023 Apr; 4(4):245-251.e3. PubMed ID: 36905929
[TBL] [Abstract][Full Text] [Related]
28. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
[TBL] [Abstract][Full Text] [Related]
29. Studying the role of dystrophin-associated proteins in influencing Becker muscular dystrophy disease severity.
van den Bergen JC; Wokke BH; Hulsker MA; Verschuuren JJ; Aartsma-Rus AM
Neuromuscul Disord; 2015 Mar; 25(3):231-7. PubMed ID: 25633150
[TBL] [Abstract][Full Text] [Related]
30. Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy.
Kleopa KA; Drousiotou A; Mavrikiou E; Ormiston A; Kyriakides T
Hum Mol Genet; 2006 May; 15(10):1623-8. PubMed ID: 16595608
[TBL] [Abstract][Full Text] [Related]
31. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
[TBL] [Abstract][Full Text] [Related]
32. Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background.
Rodrigues M; Echigoya Y; Maruyama R; Lim KR; Fukada SI; Yokota T
Sci Rep; 2016 Dec; 6():38371. PubMed ID: 27924830
[TBL] [Abstract][Full Text] [Related]
33. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin.
Marshall JL; Oh J; Chou E; Lee JA; Holmberg J; Burkin DJ; Crosbie-Watson RH
Hum Mol Genet; 2015 Apr; 24(7):2011-22. PubMed ID: 25504048
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic utility of skin biopsy in dystrophinopathies.
Tanveer N; Sharma MC; Sarkar C; Gulati S; Kalra V; Singh S; Bhatia R
Clin Neurol Neurosurg; 2009 Jul; 111(6):496-502. PubMed ID: 19251360
[TBL] [Abstract][Full Text] [Related]
35. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
Miura P; Jasmin BJ
Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
[TBL] [Abstract][Full Text] [Related]
36. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease.
Gibbs EM; McCourt JL; Shin KM; Hammond KG; Marshall JL; Crosbie RH
Hum Mol Genet; 2021 Apr; 30(3-4):149-159. PubMed ID: 33432327
[TBL] [Abstract][Full Text] [Related]
37. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
Ito M; Ehara Y; Li J; Inada K; Ohno K
Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
[TBL] [Abstract][Full Text] [Related]
38. Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy.
Gordon BS; Lowe DA; Kostek MC
Muscle Nerve; 2014 Jun; 49(6):915-8. PubMed ID: 24375286
[TBL] [Abstract][Full Text] [Related]
39. Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials.
Arechavala-Gomeza V; Kinali M; Feng L; Guglieri M; Edge G; Main M; Hunt D; Lehovsky J; Straub V; Bushby K; Sewry CA; Morgan JE; Muntoni F
Neuromuscul Disord; 2010 May; 20(5):295-301. PubMed ID: 20395141
[TBL] [Abstract][Full Text] [Related]
40. The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy.
Guiraud S; Edwards B; Babbs A; Squire SE; Berg A; Moir L; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jul; 28(13):2189-2200. PubMed ID: 30990876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
